Role of 18F-FDG PET/CT in Gastric Cancer
NCT05687552 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-01-18
Summary
The objective of the study is to assess the value of PET/CT in diagnosis, staging, response evaluation, and relapse monitoring of gastric cancer.
Conditions
Interventions
- DEVICE
-
pet -ct
assessment of added value of pet -ct in patients with gastric cancer and how patient get benefit from this finding
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
wafaa elmaghraby, ass prof · Sohag University
-
mohamed soliman, prof · Sohag University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2023-12-31
- Completion
- 2024-01-31
More Related Trials
-
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
NCT06543108 ·Status: RECRUITING
-
Study of CT and MR in the Gastric Cancer
NCT04028375 ·Status: UNKNOWN
-
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526 ·Status: RECRUITING
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Energy CT in Imaging and Diagnosis of Gastric Cancer
NCT06869694 ·Status: RECRUITING
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
NCT06182644 ·Status: RECRUITING ·Phase: NA
-
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
NCT05855278 ·Status: COMPLETED ·Phase: NA
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
Added Value of PET/CT in Lung Cancer
NCT06494800 ·Status: NOT_YET_RECRUITING
-
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
NCT07217704 ·Status: RECRUITING ·Phase: PHASE3
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
NCT03636607 ·Status: WITHDRAWN ·Phase: NA
-
Study of 18F-FAPI Applied to Gastrointestinal Cancer
NCT05788874 ·Status: UNKNOWN
-
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
NCT04395651 ·Status: UNKNOWN
-
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
NCT07285564 ·Status: RECRUITING ·Phase: NA
-
Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection
NCT06945432 ·Status: COMPLETED
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of 99mTc-FAPI SPECT/CT and 68Ga-FAPI PET/CT
NCT05444686 ·Status: UNKNOWN ·Phase: NA
-
PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
NCT05707078 ·Status: RECRUITING ·Phase: NA
-
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
NCT05420558 ·Status: UNKNOWN
-
PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer
NCT00656760 ·Status: COMPLETED ·Phase: NA
-
CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy
NCT04913896 ·Status: UNKNOWN